Lavender Essential Oil and Its Terpenic Components Negatively Affect Tumor Properties in a Cell Model of Glioblastoma DOI Creative Commons
Miriam Russo, Noemi Martella, Deborah Gargano

et al.

Molecules, Journal Year: 2024, Volume and Issue: 29(24), P. 6044 - 6044

Published: Dec. 22, 2024

Glioblastoma (GBM) is the most common and aggressive form of brain cancer in adults, characterized by extensive growth, a high recurrence rate, resistance to treatment. Growing research interest focusing on biological roles natural compounds due their potential beneficial effects health. Our aimed investigate lavender essential oil (LEO) GBM cell model. Chemical characterization using GC-MS analysis indicated that LEO contains several terpenes, have been found exhibit anticancer properties interfering with key cancer-related pathways models. By means biology assays, we demonstrated impairs proliferation migration, also reduces oxidative stress U87 cells. We further observed Terpinen-4-ol, contained LEO, was capable reproducing results suggest terpenic molecules present could be considered valuable allies alongside conventional therapies against GBM.

Language: Английский

Nanotechnology-based biomedical devices in the cancer diagnostics and therapy DOI
Junaid Tantray, Akhilesh Patel,

Hiba Parveen

et al.

Medical Oncology, Journal Year: 2025, Volume and Issue: 42(2)

Published: Jan. 20, 2025

Language: Английский

Citations

4

For and against tumor microenvironment: Nanoparticle-based strategies for active cancer therapy DOI Creative Commons

Soroush Karimi,

Roksana Bakhshali,

Soheil Bolandi

et al.

Materials Today Bio, Journal Year: 2025, Volume and Issue: 31, P. 101626 - 101626

Published: March 1, 2025

Cancer treatment is challenged by the tumor microenvironment (TME), which promotes drug resistance and cancer cell growth. This review offers a comprehensive innovative perspective on how nanomedicine can modify TME to enhance therapy. Strategies include using nanoparticles improve oxygenation, adjust acidity, alter extracellular matrix, making treatments more effective. Additionally, immune responses activating cells reducing suppression within tumors. By integrating these approaches with existing therapies, such as chemotherapy radiotherapy, show promise in overcoming traditional barriers. The discusses changes effectiveness of itself, creating reciprocal relationship that boosts overall efficacy. We also highlight novel strategies aimed at exploiting TME, leveraging nanoparticle-based for targeted therapy through precise modulation.

Language: Английский

Citations

4

Silver Nanoparticles in Therapeutics and Beyond: A Review of Mechanism Insights and Applications DOI Creative Commons
Furkan Eker, Hatice Duman, Emir Akdaşçi

et al.

Nanomaterials, Journal Year: 2024, Volume and Issue: 14(20), P. 1618 - 1618

Published: Oct. 10, 2024

Silver nanoparticles (NPs) have become highly promising agents in the field of biomedical science, offering wide therapeutic potential due to their unique physicochemical properties. The characteristics silver NPs, such as higher surface-area-to-volume ratio, make them ideal for a variety biological applications. They are easily processed thanks large surface area, strong plasmon resonance (SPR), stable nature, and multifunctionality. With an emphasis on mechanisms action, efficacy, prospective advantages this review attempts give thorough overview numerous applications these particles. utilization NPs diagnostics, bioimaging biosensing, well functions interventions antimicrobial therapies, cancer therapy, diabetes treatment, bone repair, wound healing, investigated. underlying processes by which exercise effects, oxidative stress induction, apoptosis, microbial cell membrane rupture, explored. Furthermore, toxicological concerns regulatory issues discussed, present difficulties restrictions related application medicine.

Language: Английский

Citations

14

Natural compounds as modulators of miRNAs: a new frontier in bladder cancer treatment DOI
Ahmed I. Abulsoud, Shaza H. Aly,

Sherif S. Abdel Mageed

et al.

Medical Oncology, Journal Year: 2025, Volume and Issue: 42(3)

Published: Jan. 30, 2025

Language: Английский

Citations

1

Harnessing nanoparticles for reshaping tumor immune microenvironment of hepatocellular carcinoma DOI Creative Commons
Jinsong Li,

GuanBo Zhang,

Gang Li

et al.

Discover Oncology, Journal Year: 2025, Volume and Issue: 16(1)

Published: Feb. 5, 2025

Hepatocellular carcinoma (HCC) is one of the most prevalent cancers, characterized by high morbidity and mortality rates. Recently, immunotherapy has emerged as a crucial treatment modality for HCC, following surgery, locoregional therapies, targeted therapies. This approach harnesses body's immune system to target eliminate cancer cells, potentially resulting in durable antitumor responses. However, acquired resistance tumor immunosuppressive microenvironment (TIME) significantly hinder its clinical application. advancements nanotechnology, coupled with deeper understanding biology nano-biological interactions, have led development various nanoparticles aimed at enhancing therapeutic efficacy through specific targeting tissues. These increase accumulation immunotherapeutic drugs within microenvironment, thereby transforming TIME. In this review, we provide concise overview fundamental principles governing TIME landscape HCC discuss rationale applications context. Additionally, highlight existing challenges potential opportunities translation nanomedicines.

Language: Английский

Citations

1

How Advanced are Self-Assembled Nanomaterials for Targeted Drug Delivery? A Comprehensive Review of the Literature DOI Creative Commons
Hamdi Nsairat, Zainab Lafi, Belal O. Al-Najjar

et al.

International Journal of Nanomedicine, Journal Year: 2025, Volume and Issue: Volume 20, P. 2133 - 2161

Published: Feb. 1, 2025

The development of effective drug delivery systems is a key focus in pharmaceutical research, aiming to enhance therapeutic efficacy while minimizing adverse effects. Self-assembled nanostructures present promising solution due their tunable properties, biocompatibility, and ability encapsulate deliver agents specific targets. This review examines recent advancements drug-based self-assembled for targeted applications, including drug-drug conjugates, polymeric-based architectures, biomolecules, peptides, DNA, squalene conjugates amphiphilic drugs. Various strategies fabricating these are discussed, with an emphasis on the design principles mechanisms underlying self-assembly potential tissues or cells. Furthermore, integration targeting ligands, stimuli-responsive moieties imaging into explored enhanced outcomes real-time monitoring. Challenges such as stability, scalability regulatory hurdles translating from bench bedside also addressed. Drug-based represent platform developing next-generation improved reduced side

Language: Английский

Citations

1

Emerging Role of Hypoxia-Inducible Factors (HIFs) in Modulating Autophagy: Perspectives on Cancer Therapy DOI Open Access
Maroua Jalouli

International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(4), P. 1752 - 1752

Published: Feb. 19, 2025

Hypoxia-inducible factors (HIFs) are master regulators of cellular responses to low oxygen levels and modulate autophagy, a conserved process essential for maintaining homeostasis. Under hypoxic conditions, HIFs regulate the expression autophagy-related genes influence autophagic flux stress responses. Dysregulated hypoxia-induced autophagy promotes cancer cell survival, metabolism, metastasis, thereby contributing treatment resistance. Targeting HIF-mediated pathways or modulating processes offers potential improve traditional therapies overcome drug Pharmacological inhibitors either alone in combination with other treatments, may disrupt pro-survival mechanisms within tumor microenvironment. Further research is needed elucidate intricate interplay between HIF signaling machinery cells. Understanding these could pave way novel therapeutic strategies enhance outcomes combat This review highlights complex relationship development therapy, offering insights into how targeting patient outcomes.

Language: Английский

Citations

1

Nanoparticle-Based Delivery Systems for Phytochemicals in Cancer Therapy: Molecular Mechanisms, Clinical Evidence, and Emerging Trends DOI
Mahmoud A.H. Mostafa, Hani M. J. Khojah

Drug Development and Industrial Pharmacy, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 31

Published: March 21, 2025

This review examines recent advancements in nanoparticle-based delivery systems for phytochemicals, focusing on their role overcoming multidrug resistance, improving therapeutic efficacy, and facilitating clinical translation. highlights advances nanoparticle-enabled phytochemical to enhance bioavailability, improve outcomes, enable targeted applications. By comparing various nanoparticle systems, formulation methods, efficacy data, it identifies gaps current research guides the development of more effective, next-generation phytochemical-loaded nanocarriers. A systematic literature published between 2000 2024 was conducted using PubMed, Scopus, Web Science. Articles cancer therapy were included. Compounds such as curcumin, resveratrol, quercetin, epigallocatechin gallate demonstrate enhanced anti-cancer when encapsulated nanoparticles, leading improved increased tumor cell targeting, reduced toxicity. Clinical trials indicate regression fewer adverse effects. Emerging approaches-such nanogels, hybrid combination therapies with immune checkpoint inhibitors-further refine treatment efficacy. Nanoparticle-based significantly potential making them promising candidates safer, effective treatments. However, challenges related regulatory guidelines, scalability, long-term safety must be addressed fully realize potential.

Language: Английский

Citations

1

Therapeutic Potential of Terpenoids in Cancer Treatment: Targeting Mitochondrial Pathways DOI Creative Commons
Jianxin Guo, Ming Huang, Shuang Hou

et al.

Cancer Reports, Journal Year: 2024, Volume and Issue: 7(9)

Published: Sept. 1, 2024

ABSTRACT Background In recent decades, natural compounds have been considered a significant source of new antitumor medicines due to their unique advantages. Several in vitro and vivo studies focused on the effect terpenoids apoptosis mediated by mitochondria malignant cells. Recent findings this review article, we six extensively studied terpenoids, including sesquiterpenes (dihydroartemisinin parthenolide), diterpenes (oridonin triptolide), triterpenes (betulinic acid oleanolic acid), efficacy targeting induce cell death. Terpenoid‐induced mitochondria‐related death includes apoptosis, pyroptosis, necroptosis, ferroptosis, autophagy, necrosis caused mitochondrial permeability transition. Apoptosis autophagy interact meaningful ways. addition, view several disadvantages such as low stability bioavailability, advances research combination chemotherapy chemical modification were surveyed. Conclusion This article deepens our understanding association between death, presenting hypothetical basis for use anticancer management.

Language: Английский

Citations

4

Cryptolepine-transferrin nanosystem preparation and the anticancer effects on human malignant glioblastoma U87MG cells DOI
Xuechao Dong, Xing Su,

Yantao Jin

et al.

International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: 303, P. 140627 - 140627

Published: Feb. 2, 2025

Language: Английский

Citations

0